| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/19/1999 | US5861483 Inhibitor of stem cell proliferation and uses thereof |
| 01/19/1999 | US5861436 Inhibitors of the relese of tumor necrosis factor |
| 01/19/1999 | US5861433 Prevention and improvement of inflammation caused by leucotriene B4 |
| 01/19/1999 | US5861402 1,4-dihydropyridine compounds |
| 01/19/1999 | US5861394 Use of N-substituted phenothiazines |
| 01/19/1999 | US5861384 Suppression of rejection after transplants for organs orally in an amount in the range of about 5 to 2000 mg. |
| 01/19/1999 | US5861314 Genetic manipulation which comprises a liposome comprised of lipid material, and adeno-associated viral (aav) material for genomes |
| 01/19/1999 | US5861171 Adeno-associated viral (AAV) liposomes and methods related thereto |
| 01/19/1999 | US5861159 Controlled release of pharmaceutically active substances for immunotherapy |
| 01/19/1999 | US5861155 Humanized antibodies and uses thereof |
| 01/19/1999 | US5861151 Soluble fusion molecules with binding specificity for cell adhesion molecules |
| 01/19/1999 | CA2215339C Immunomodulating compositions from bile for the treatment of immune system disorders |
| 01/19/1999 | CA2139552C Use of self-incompatibility receptor proteins (slg and srk) of plants for the treatment of allergic diseases |
| 01/19/1999 | CA2002105C Dideoxy-l-arabinitol derivatives as antiviral compounds |
| 01/19/1999 | CA1340327C Mhc-mediated toxic conjugates useful in ameliorating autoimmunity |
| 01/18/1999 | CA2237147A1 Novel ratb |
| 01/18/1999 | CA2237143A1 Novel rata |
| 01/18/1999 | CA2237140A1 Novel tarf |
| 01/18/1999 | CA2237050A1 Histidine kinase |
| 01/14/1999 | WO1999001556A2 IMPROVED ANTI-IgE ANTIBODIES AND METHOD OF IMPROVING POLYPEPTIDES |
| 01/14/1999 | WO1999001467A2 Therapeutically active compounds with low systemic activity due to reduce half life |
| 01/14/1999 | WO1999001466A1 Secreted proteins and polynucleotides encoding them |
| 01/14/1999 | WO1999001458A1 Crystalline macrolides and process for their preparation |
| 01/14/1999 | WO1999001452A1 Novel cycloalkyl substituted imidazoles |
| 01/14/1999 | WO1999001451A1 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists |
| 01/14/1999 | WO1999001450A1 POLYMORPHS OF 8-CHLORO-6, 11-DIHYDRO-11- (4-PIPERIDYLIDENE) -5H-BENZO[5,6] CYCLOHEPTA[1,2-b]PYRIDINE |
| 01/14/1999 | WO1999001449A1 2-substituted 4,5-diaryl imidazoles |
| 01/14/1999 | WO1999001439A1 Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists |
| 01/14/1999 | WO1999001434A1 Inhibitors of farnesyl protein transferase |
| 01/14/1999 | WO1999001426A1 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors |
| 01/14/1999 | WO1999001421A1 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors |
| 01/14/1999 | WO1999001416A2 1-amino-alkylcyclohexane nmda receptor antagonists |
| 01/14/1999 | WO1999001137A1 Azelastine hydrochloride-containing percutaneous preparation having good percutaneous absorbability and reduced skin irritation |
| 01/14/1999 | WO1999001136A1 Novel substituted imidazole compounds |
| 01/14/1999 | WO1999001133A1 Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin |
| 01/14/1999 | WO1999001131A1 Novel substituted imidazole compounds |
| 01/14/1999 | WO1999001130A1 Novel substituted imidazole compounds |
| 01/14/1999 | WO1999001127A1 Compounds and methods |
| 01/14/1999 | WO1999001123A1 Low dosed 15-desoxyspergualine preparations |
| 01/14/1999 | WO1999001117A2 Inhibitors of nf-kappab as activators of hsf and inducers of heat shock proteins |
| 01/14/1999 | WO1998039029A3 Pharmaceutical or food composition for treating pathologies related to graft versus host, allergic or autoimmune reaction |
| 01/14/1999 | WO1998038212A3 Chimeric polypeptides containing chemokine domains |
| 01/14/1999 | WO1998036067A3 Secreted proteins and polynucleotides encoding them |
| 01/14/1999 | CA2615842A1 Polymorphs of 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5h-benzo[5,6]cyclohepta[1,2-b]pyridine |
| 01/14/1999 | CA2296014A1 Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists |
| 01/14/1999 | CA2295762A1 Novel cycloalkyl substituted imidazoles |
| 01/14/1999 | CA2295228A1 Novel substituted imidazole compounds |
| 01/14/1999 | CA2295212A1 Secreted proteins and polynucleotides encoding them |
| 01/14/1999 | CA2294785A1 Low dosed 15-desoxyspergualine preparations |
| 01/14/1999 | CA2294770A1 Compounds and methods |
| 01/14/1999 | CA2294764A1 Inhibitors of nf-kappab as activators of hsf and inducers of heat shock proteins |
| 01/14/1999 | CA2294530A1 Inhibitors of farnesyl protein transferase |
| 01/14/1999 | CA2294524A1 Novel substituted imidazole compounds |
| 01/14/1999 | CA2294522A1 Novel substituted imidazole compounds |
| 01/14/1999 | CA2294193A1 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists |
| 01/14/1999 | CA2291758A1 2-substituted 4,5-diaryl imidazoles |
| 01/14/1999 | CA2290509A1 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors |
| 01/13/1999 | EP0890641A1 Novel IspA |
| 01/13/1999 | EP0889972A1 Diagnostic method and apparatus |
| 01/13/1999 | EP0889964A1 Soluble divalent and multivalent heterodimeric analogs of proteins |
| 01/13/1999 | EP0889961A2 Monocyte chemotactic protein-5 materials and methods |
| 01/13/1999 | EP0889905A1 Cytokine antagonists and agonists |
| 01/13/1999 | EP0889894A1 Phosphoramidates and phosphinic amides, their use to modulate the activity of endothelin |
| 01/13/1999 | EP0889888A1 Novel treatment for cns injuries |
| 01/13/1999 | EP0889887A1 Novel treatment for cns injuries |
| 01/13/1999 | EP0889728A2 Method of treating ciliary dyskinesia with uridine triphosphates and related compounds |
| 01/13/1999 | CN1205009A Pyrazolopyrimidines type compound |
| 01/13/1999 | CN1204532A Ginseng, Chinese angelica liquor and its manufacturing method |
| 01/13/1999 | CN1041631C Novel carbocyclic nucleoside agents useful as selective inhititors of proinflammatory cell factor |
| 01/12/1999 | US5859271 Inhibitors of phospholipase that prevent phospholipase mediated injury, injury due to oxidation, and inflammation; side effect reduction |
| 01/12/1999 | US5859257 Isoxazole compounds as cyclooxygenase inhibitors |
| 01/12/1999 | US5859253 Metalloproteinase inhibitors |
| 01/12/1999 | US5859244 1,4-dihydropyridine derivatives and methods of producing the same |
| 01/12/1999 | US5859223 Dna molecules coding for no more than three short consensus repeats including scr3 of long homologous repeat a of complement receptor 1; antiinflammatory agents; multiple sclerosis; parkinson's/alzheimer's disease |
| 01/12/1999 | US5859201 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 01/12/1999 | US5859046 Biologically active oreido derivatives useful in the treatment of multiple sclerosis |
| 01/12/1999 | US5859041 Substituted imidazoles having cytokine inhibitory activity |
| 01/12/1999 | US5859034 Tri-substituted phenyl compounds which have useful pharmaceutical activity |
| 01/12/1999 | US5859031 Small molecule inhibitors of rotamase enzyme activity |
| 01/12/1999 | US5859029 Heterocyclic compounds method of preparing them and pharmeutical compositions in which they are present |
| 01/12/1999 | US5859021 Antiviral combinations |
| 01/12/1999 | US5859011 Dihydropyridine derivatives as bradykinin antagonist |
| 01/12/1999 | US5859008 Arylalkyl diazinones |
| 01/12/1999 | US5859006 Tetracyclic derivatives; process of preparation and use |
| 01/12/1999 | US5859003 Antiallergens, antiasthmatics |
| 01/12/1999 | US5859000 Method for reducing mast cell mediated allergic reactions |
| 01/12/1999 | US5858980 Peptide fragments of myelin basic protein |
| 01/12/1999 | US5858978 Pharmaceutical compositions containing calcitonin gene-related peptide (CGRP) and use thereof to ameliorate hyperimmune mediated diseases and abnormal conditions |
| 01/12/1999 | US5858969 Administering to treat adult respiratory distress syndrome |
| 01/12/1999 | US5858968 Autoimmune model: insulin not used for its endocrinologic effect (does not affect blood sugar levels), but to damp down the host's autoimmune response and prevent autoimmune destruction of pancreatic beta cells, allowing oral dosing |
| 01/12/1999 | US5858965 Pharmaceutical compositions for the treatment of autoimmune diseases comprising the B-oligomer of pertussis toxin or its subunits |
| 01/12/1999 | US5858964 Immunosuppressant |
| 01/12/1999 | US5858963 Inducing xenograft tolerance and porcine cytokines therefor |
| 01/12/1999 | US5858758 Human serine protease precursor |
| 01/12/1999 | US5858716 H2CAA71 polynucleotides |
| 01/12/1999 | US5858376 Introducing into cell isolated protein derived from herpes simplex virus |
| 01/12/1999 | US5858373 Recombinant poxvirus-feline infectious peritionitis virus, compositions thereof and methods for making and using them |
| 01/12/1999 | US5858368 Vaccine comprising a baculovirus produced influenza hemagglutinin protein fused to a second protein |
| 01/10/1999 | CA2236485A1 Novel 1spa |
| 01/07/1999 | WO1999000510A1 Regulation of transcription in mammalian cells and viral replication by a tetracyclin repressor |